Has Sandy Wong received payments from drug or device companies?

Yes. Drug and device makers reported $28,526 in general payments to Sandy Wong across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandy Wong did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandy Wong come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandy Wong

Internal Medicine · San Francisco, CANPI 1396972956

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $18,759 of the $28,526 with a category attached, or 65.8%. 13 manufacturers reported payments, led by Sanofi at 51.6% of the total. Reporting peaked in 2023 at $8,797 and has fallen 98.5% since, to $128 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,526in general payments, 2019–2025

Across 22 payments — averaging $1296.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$15K
Pfizer$6K
Amgen$2K
GSK$2K
Janssen Scientific Affairs, LLC$2K
F. Hoffmann-la Roche AG$485
plus $490 from 7 others

$6,612,563in research payments, 2019–2025

Across 61 payments — averaging $108,403 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bristol Myers Squibb$5.5M
Janssen Research & Development, LLC$671K
AstraZeneca$227K
Genentech, Inc.$143K
GSK$44K

What the payments were for

Consulting fees$18,75966%
Speaking & faculty fees$9,10032%
Food & beverage$6672%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	7	$14,728
Pfizer	2	$6,255
Amgen	1	$2,400
GSK	1	$2,400
Janssen Scientific Affairs, LLC	1	$1,768
F. Hoffmann-la Roche AG	2	$485
Johnson & Johnson Surgical Vision, Inc.	1	$128
AstraZeneca	1	$125
Johnson & Johnson	1	$82
Bristol Myers Squibb	1	$69
E.r. Squibb & Sons, L.L.C.	2	$44
AbbVie	1	$25
Pharmacyclics LLC, An Abbvie Company	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,526 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in San Francisco

Fred CohenSan Francisco$929K
John TeerlinkSan Francisco$819K
Mark SmithSan Francisco$535K
Lisa CapaldiniSan Francisco$434K
Maria Dall'eraSan Francisco$417K
Kenneth ColleySan Francisco$397K
Louis CubbaSan Francisco$351K
Daniel ButlerSan Francisco$347K
Laurence CorashSan Francisco$336K
Felicia StermanSan Francisco$298K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →